ACHILLEA MILLEFOLIUM, ARNICA MONTANA, HYPERICUM PERFORATUM, HORSE CHESTNUT, AND VISCUM ALBUM WHOLE

ACHILLEA MILLEFOLIUM, ARNICA MONTANA, HYPERICUM PERFORATUM, HORSE CHESTNUT, AND VISCUM ALBUM WHOLE was reported 1541 times

ACHILLEA MILLEFOLIUM, ARNICA MONTANA, HYPERICUM PERFORATUM, HORSE CHESTNUT, AND VISCUM ALBUM WHOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE HYPERTROPHY 1 0.0714
1 DIVERSION COLITIS 1 0.0303
2 BLOOD PRESSURE MANAGEMENT 1 0.0250
3 CLITORAL ENGORGEMENT 1 0.0250
4 EXERCISE ELECTROCARDIOGRAM ABNORMAL 1 0.0120
5 COELIAC ARTERY STENOSIS 1 0.0110
6 GINGIVAL ATROPHY 2 0.0102
7 ATROPHIC GLOSSITIS 1 0.0092
8 THUNDERCLAP HEADACHE 2 0.0076
9 ADMINISTRATION SITE IRRITATION 1 0.0071
10 BASOSQUAMOUS CARCINOMA 1 0.0067
11 EYELASH CHANGES 1 0.0056
12 EYELID SENSORY DISORDER 1 0.0051
13 DYSBACTERIOSIS 1 0.0047
14 BONE MARROW TRANSPLANT REJECTION 1 0.0045
15 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
16 CARDIAC PERFORATION 1 0.0043
17 ASPARTATE AMINOTRANSFERASE 1 0.0041
18 CHRONIC GASTROINTESTINAL BLEEDING 1 0.0039
19 COATING IN MOUTH 2 0.0037
20 EAR NEOPLASM 1 0.0036
21 OSTEOGENESIS IMPERFECTA 2 0.0034
22 BACTERIAL TEST 1 0.0034
23 BREAST INFLAMMATION 1 0.0032
24 FEMORAL ARTERY OCCLUSION 1 0.0032
25 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
26 FEMALE ORGASMIC DISORDER 1 0.0030
27 BLOOD TRIGLYCERIDES DECREASED 1 0.0030
28 INJECTION SITE MACULE 2 0.0029
29 ANDROGEN DEFICIENCY 1 0.0028
30 MYOFASCIAL PAIN SYNDROME 2 0.0028
31 TOE OPERATION 2 0.0025
32 ENDOCARDITIS BACTERIAL 2 0.0025
33 PHYSICAL PRODUCT LABEL ISSUE 3 0.0025
34 HEAT EXHAUSTION 2 0.0025
35 MITOCHONDRIAL TOXICITY 2 0.0024
36 CANDIDA TEST POSITIVE 1 0.0024
37 SENSATION OF PRESSURE 2 0.0023
38 GLYCOSURIA 3 0.0022
39 CHRONIC FATIGUE SYNDROME 3 0.0022
40 ENDOCARDITIS STAPHYLOCOCCAL 1 0.0020
41 CSF TEST ABNORMAL 1 0.0020
42 NON-ALCOHOLIC STEATOHEPATITIS 2 0.0019
43 PRODUCT COMMINGLING 2 0.0019
44 BLOOD IMMUNOGLOBULIN A INCREASED 1 0.0019
45 AUTOSCOPY 1 0.0019
46 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
47 EXECUTIVE DYSFUNCTION 1 0.0018
48 EJACULATION DELAYED 1 0.0018
49 BURN ORAL CAVITY 1 0.0017
50 DYSLEXIA 2 0.0017
51 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
52 DRUG MONITORING PROCEDURE NOT PERFORMED 3 0.0017
53 ATROPHY 3 0.0015
54 CELLULITIS STAPHYLOCOCCAL 1 0.0015
55 JOINT CREPITATION 3 0.0015
56 BLOOD OESTROGEN DECREASED 1 0.0014
57 FACIAL DISCOMFORT 1 0.0014
58 TEMPERATURE REGULATION DISORDER 3 0.0013
59 HYPOSMIA 2 0.0013
60 ARTERIAL RUPTURE 1 0.0013
61 DRUG TOLERANCE INCREASED 1 0.0013
62 BLISTER INFECTED 1 0.0013
63 AORTIC DISORDER 1 0.0013
64 COLON CANCER METASTATIC 2 0.0012
65 TENDON DISORDER 8 0.0012
66 FEAR OF FALLING 1 0.0012
67 BREAST OPERATION 1 0.0012
68 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
69 INJECTION RELATED REACTION 2 0.0012
70 DEPERSONALISATION 1 0.0012
71 COVID-19 IMMUNISATION 1 0.0012
72 VEIN RUPTURE 2 0.0012
73 TENDON PAIN 9 0.0012
74 MUSCLE FATIGUE 5 0.0012
75 ELECTRIC SHOCK 1 0.0012
76 CORONARY ARTERY DISSECTION 1 0.0012
77 ENTEROVIRUS INFECTION 1 0.0012
78 OTORRHOEA 2 0.0011
79 DRUG LEVEL FLUCTUATING 1 0.0011
80 WEIGHT BEARING DIFFICULTY 3 0.0011
81 APPARENT DEATH 4 0.0011
82 UTERINE SPASM 2 0.0011
83 COLOUR BLINDNESS 1 0.0011
84 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
85 LYMPH NODE PAIN 2 0.0011
86 CATHETER SITE SWELLING 1 0.0011
87 BUNDLE BRANCH BLOCK 1 0.0011
88 INTERVERTEBRAL DISCITIS 2 0.0011
89 ADRENAL DISORDER 2 0.0010
90 GINGIVAL RECESSION 2 0.0010
91 BLOOD URINE 1 0.0010
92 VOMITING PROJECTILE 3 0.0010
93 BONE SWELLING 1 0.0010
94 SENSATION OF HEAVINESS 4 0.0010
95 EYELID RASH 1 0.0010
96 HYPOGEUSIA 2 0.0010
97 DACTYLITIS 1 0.0010
98 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 1 0.0009
99 VITREOUS DETACHMENT 2 0.0009
100 REACTION TO DRUG EXCIPIENTS 2 0.0009
101 TONGUE DISCOLOURATION 4 0.0009
102 PRODUCT FORMULATION ISSUE 6 0.0009
103 CYSTIC FIBROSIS 5 0.0009
104 INJECTION SITE PAPULE 4 0.0009
105 CHEMICAL BURN 1 0.0009
106 FOLATE DEFICIENCY 1 0.0009
107 MUSCLE DISORDER 7 0.0009
108 ALLODYNIA 1 0.0009
109 URINARY TRACT OBSTRUCTION 2 0.0008
110 SINUS OPERATION 2 0.0008
111 BLADDER PROLAPSE 1 0.0008
112 BLADDER DISCOMFORT 1 0.0008
113 APPLICATION SITE SCAR 1 0.0008
114 IMPAIRED WORK ABILITY 17 0.0008
115 APPLICATION SITE WARMTH 1 0.0008
116 FACIAL PAIN 7 0.0008
117 TENDONITIS 12 0.0008
118 CALCIUM DEFICIENCY 1 0.0008
119 FOREIGN BODY IN RESPIRATORY TRACT 1 0.0008
120 CARDIOACTIVE DRUG LEVEL INCREASED 1 0.0008
121 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
122 PRODUCT SUBSTITUTION ISSUE 43 0.0007
123 QUALITY OF LIFE DECREASED 10 0.0007
124 SKIN DISCOMFORT 2 0.0007
125 ANORGASMIA 2 0.0007
126 MIGRAINE WITH AURA 2 0.0007
127 SKIN WRINKLING 2 0.0007
128 AGORAPHOBIA 1 0.0007
129 ABSCESS ORAL 1 0.0007
130 BILIARY TRACT DISORDER 1 0.0007
131 TRICHORRHEXIS 2 0.0007
132 HYPERTONIC BLADDER 2 0.0007
133 SKIN WARM 4 0.0007
134 DARK CIRCLES UNDER EYES 1 0.0007
135 GINGIVAL SWELLING 3 0.0007
136 MUSCLE TIGHTNESS 11 0.0007
137 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
138 EXCESSIVE EYE BLINKING 1 0.0007
139 FEELING DRUNK 5 0.0007
140 ADHESION 1 0.0007
141 ASTIGMATISM 1 0.0007
142 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
143 CALCULUS URINARY 1 0.0006
144 BACTERIAL VAGINOSIS 1 0.0006
145 PHOTOPSIA 4 0.0006
146 CHRONIC LYMPHOCYTIC LEUKAEMIA 3 0.0006
147 CYSTITIS INTERSTITIAL 1 0.0006
148 AORTIC VALVE DISEASE 1 0.0006
149 ABNORMAL FAECES 5 0.0006
150 BLOOD CALCIUM ABNORMAL 1 0.0006
151 VEIN DISORDER 3 0.0006
152 INTERNATIONAL NORMALISED RATIO ABNORMAL 2 0.0006
153 EMOTIONAL POVERTY 1 0.0006
154 POLYARTHRITIS 3 0.0006
155 SCIATICA 9 0.0006
156 STRESS FRACTURE 3 0.0006
157 ACTIVITIES OF DAILY LIVING IMPAIRED 11 0.0006
158 CHEILITIS 3 0.0006
159 DEVICE ALARM ISSUE 1 0.0006
160 ESSENTIAL HYPERTENSION 1 0.0005
161 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
162 PARADOXICAL DRUG REACTION 2 0.0005
163 BLINDNESS TRANSIENT 4 0.0005
164 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
165 HYPERACUSIS 2 0.0005
166 AURA 1 0.0005
167 THROAT CLEARING 2 0.0005
168 BLOOD IRON INCREASED 1 0.0005
169 BEDRIDDEN 7 0.0005
170 SPINAL DISORDER 5 0.0005
171 LOSS OF CONTROL OF LEGS 2 0.0005
172 CLAVICLE FRACTURE 2 0.0005
173 EXERCISE TOLERANCE DECREASED 3 0.0005
174 MUSCLE TWITCHING 12 0.0005
175 GINGIVAL DISORDER 2 0.0005
176 MOUTH SWELLING 3 0.0005
177 FAECES HARD 2 0.0005
178 OESOPHAGEAL PAIN 2 0.0005
179 GINGIVAL PAIN 4 0.0005
180 FOREIGN BODY 2 0.0005
181 ENURESIS 2 0.0005
182 VITAMIN B12 DEFICIENCY 2 0.0005
183 EYELID PAIN 1 0.0005
184 DERMATITIS PSORIASIFORM 1 0.0005
185 GOITRE 2 0.0005
186 HYPERAESTHESIA 4 0.0005
187 SOCIAL PROBLEM 2 0.0005
188 THINKING ABNORMAL 9 0.0005
189 BODY TEMPERATURE FLUCTUATION 1 0.0005
190 ONYCHOMADESIS 2 0.0005
191 EYE CONTUSION 1 0.0005
192 CARDIAC OPERATION 4 0.0005
193 BLOOD TESTOSTERONE INCREASED 1 0.0005
194 DEREALISATION 1 0.0005
195 HYPOAESTHESIA ORAL 7 0.0005
196 MONOPLEGIA 2 0.0005
197 LOCAL SWELLING 8 0.0005
198 DYSPHEMIA 2 0.0005
199 CORNEAL DISORDER 1 0.0005
200 GROIN PAIN 4 0.0005
201 DYSGRAPHIA 3 0.0005
202 CLOSTRIDIUM TEST POSITIVE 1 0.0005
203 NEURALGIA 11 0.0005
204 DANDRUFF 1 0.0005
205 BLOOD CREATINE INCREASED 2 0.0005
206 FAECES PALE 1 0.0004
207 CALCINOSIS 1 0.0004
208 PRODUCT LABEL ISSUE 3 0.0004
209 URINE ABNORMALITY 2 0.0004
210 IMPAIRED DRIVING ABILITY 5 0.0004
211 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
212 MUSCULOSKELETAL PAIN 23 0.0004
213 SCAB 5 0.0004
214 MOVEMENT DISORDER 14 0.0004
215 LYMPHOEDEMA 3 0.0004
216 EYELID DISORDER 1 0.0004
217 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
218 BREAKTHROUGH PAIN 1 0.0004
219 DEFAECATION URGENCY 3 0.0004
220 DISCOURAGEMENT 1 0.0004
221 VAGINAL INFECTION 2 0.0004
222 PHOTOSENSITIVITY REACTION 7 0.0004
223 COLITIS MICROSCOPIC 2 0.0004
224 EMOTIONAL DISORDER 13 0.0004
225 BLOOD IRON DECREASED 5 0.0004
226 PARALYSIS 6 0.0004
227 DIABETES INSIPIDUS 1 0.0004
228 VULVOVAGINAL PAIN 2 0.0004
229 DIZZINESS POSTURAL 4 0.0004
230 ORAL DISORDER 3 0.0004
231 DERMAL CYST 1 0.0004
232 THERAPY CHANGE 4 0.0004
233 TENDON RUPTURE 5 0.0004
234 ABASIA 10 0.0004
235 DEVICE INFUSION ISSUE 1 0.0004
236 BLADDER DISORDER 4 0.0004
237 APPLICATION SITE SWELLING 2 0.0004
238 AGEUSIA 10 0.0004
239 BREAST TENDERNESS 3 0.0004
240 PAROSMIA 3 0.0004
241 EXPOSURE VIA INGESTION 1 0.0004
242 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
243 ECONOMIC PROBLEM 6 0.0004
244 FEEDING DISORDER 8 0.0004
245 DRY THROAT 4 0.0004
246 EAR DISCOMFORT 4 0.0004
247 BLOOD CHLORIDE DECREASED 1 0.0004
248 APHTHOUS ULCER 3 0.0004
249 POOR VENOUS ACCESS 4 0.0004
250 FOOD CRAVING 2 0.0004
251 INCONTINENCE 4 0.0004
252 NASAL DISCOMFORT 3 0.0004
253 ANIMAL BITE 1 0.0004
254 BODY HEIGHT DECREASED 4 0.0004
255 MIOSIS 3 0.0004
256 BRUXISM 2 0.0004
257 GINGIVITIS 2 0.0004
258 DECREASED ACTIVITY 4 0.0004
259 TINNITUS 17 0.0004
260 PRURITUS GENERALISED 8 0.0004
261 HIP SURGERY 2 0.0004
262 CHONDROPATHY 1 0.0004
263 ABDOMINAL RIGIDITY 1 0.0004
264 POLYURIA 3 0.0004
265 PERIPHERAL COLDNESS 5 0.0004
266 ASTHENOPIA 2 0.0004
267 GASTROINTESTINAL PAIN 4 0.0004
268 TOOTH FRACTURE 4 0.0004
269 HYPERKERATOSIS 2 0.0004
270 STREPTOCOCCAL INFECTION 2 0.0004
271 COORDINATION ABNORMAL 5 0.0004
272 MASS 5 0.0004
273 REBOUND EFFECT 4 0.0004
274 CHOLECYSTITIS ACUTE 2 0.0004
275 DIPLOPIA 9 0.0003
276 EYELID MARGIN CRUSTING 1 0.0003
277 ANOSMIA 5 0.0003
278 PRODUCT LABEL CONFUSION 2 0.0003
279 DYSSTASIA 10 0.0003
280 BURNING SENSATION 24 0.0003
281 NECK PAIN 19 0.0003
282 DECREASED INTEREST 2 0.0003
283 ODYNOPHAGIA 2 0.0003
284 ACCIDENT 4 0.0003
285 TOOTHACHE 6 0.0003
286 THERAPY CESSATION 17 0.0003
287 EYE INJURY 1 0.0003
288 RETCHING 7 0.0003
289 OVARIAN CANCER 3 0.0003
290 BLOOD GLUCOSE ABNORMAL 6 0.0003
291 PALPITATIONS 38 0.0003
292 DIASTOLIC DYSFUNCTION 1 0.0003
293 MYALGIA 55 0.0003
294 FAMILY STRESS 1 0.0003
295 COGNITIVE DISORDER 15 0.0003
296 EYELIDS PRURITUS 1 0.0003
297 SECRETION DISCHARGE 4 0.0003
298 SWELLING OF EYELID 2 0.0003
299 NIGHTMARE 11 0.0003
300 BLEPHAROSPASM 2 0.0003
301 MUSCULAR WEAKNESS 36 0.0003
302 DRUG EFFECT INCREASED 1 0.0003
303 THERAPEUTIC RESPONSE CHANGED 2 0.0003
304 BLADDER PAIN 1 0.0003
305 EXPOSURE TO TOXIC AGENT 1 0.0003
306 ORAL PAIN 7 0.0003
307 POLLAKIURIA 13 0.0003
308 SENSORY DISTURBANCE 5 0.0003
309 CARDIAC FLUTTER 2 0.0003
310 VITAMIN D DEFICIENCY 3 0.0003
311 BACTERIAL SEPSIS 1 0.0003
312 POLYP 2 0.0003
313 BREAST ENLARGEMENT 1 0.0003
314 VITREOUS FLOATERS 3 0.0003
315 PULMONARY CONGESTION 4 0.0003
316 INABILITY TO AFFORD MEDICATION 3 0.0003
317 SKIN DISORDER 10 0.0003
318 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
319 CHILLS 35 0.0003
320 JOINT RANGE OF MOTION DECREASED 4 0.0003
321 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
322 FEELING HOT 18 0.0003
323 EUPHORIC MOOD 3 0.0003
324 BLOOD TESTOSTERONE DECREASED 2 0.0003
325 INJECTION SITE WARMTH 6 0.0003
326 ONYCHOCLASIS 2 0.0003
327 ABNORMAL DREAMS 8 0.0003
328 LARGE INTESTINE POLYP 2 0.0003
329 FIBROMYALGIA 7 0.0003
330 AORTIC STENOSIS 1 0.0003
331 PRODUCT ODOUR ABNORMAL 3 0.0003
332 CAROTID ARTERY STENOSIS 1 0.0003
333 INJECTION SITE URTICARIA 7 0.0003
334 EAR PRURITUS 1 0.0003
335 SCRATCH 3 0.0003
336 PAPULE 2 0.0003
337 GAIT DISTURBANCE 54 0.0003
338 NIGHT SWEATS 9 0.0003
339 PANIC REACTION 2 0.0003
340 PULMONARY THROMBOSIS 3 0.0003
341 FAECES SOFT 2 0.0003
342 BONE DISORDER 5 0.0003
343 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
344 BLOOD PHOSPHORUS DECREASED 1 0.0003
345 DYSPHONIA 16 0.0003
346 DENTAL CARIES 3 0.0003
347 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
348 HYPOPHOSPHATAEMIA 2 0.0003
349 ARTHROPOD BITE 2 0.0003
350 TOOTH DISORDER 6 0.0003
351 NERVE INJURY 3 0.0003
352 MEMORY IMPAIRMENT 37 0.0003
353 EYE SWELLING 10 0.0003
354 GLOSSODYNIA 6 0.0003
355 MIDDLE INSOMNIA 5 0.0003
356 JOINT STIFFNESS 7 0.0003
357 ANGER 9 0.0003
358 BLOOD PRESSURE INCREASED 40 0.0003
359 INSURANCE ISSUE 4 0.0003
360 COMMUNICATION DISORDER 1 0.0003
361 DISSOCIATION 2 0.0003
362 FEAR 7 0.0003
363 PAIN OF SKIN 7 0.0003
364 FOOD ALLERGY 2 0.0003
365 EAR PAIN 5 0.0003
366 PELVIC FRACTURE 2 0.0003
367 CARDIOPULMONARY FAILURE 1 0.0003
368 NERVOUS SYSTEM DISORDER 8 0.0003
369 CHOKING 5 0.0003
370 ORAL HERPES 5 0.0003
371 EPIGASTRIC DISCOMFORT 1 0.0003
372 CERVIX CARCINOMA 1 0.0003
373 FLUSHING 26 0.0003
374 BRAIN FOG 4 0.0003
375 DIVERTICULITIS 7 0.0003
376 MACULAR DEGENERATION 3 0.0003
377 PAIN IN EXTREMITY 74 0.0003
378 CEREBRAL ATROPHY 1 0.0003
379 BLOOD DISORDER 2 0.0002
380 EYE PAIN 14 0.0002
381 RHINITIS 2 0.0002
382 MENTAL IMPAIRMENT 6 0.0002
383 HYPOAESTHESIA 37 0.0002
384 TREMOR 41 0.0002
385 PANIC ATTACK 9 0.0002
386 TASTE DISORDER 5 0.0002
387 APPLICATION SITE DISCOLOURATION 1 0.0002
388 AMNESIA 16 0.0002
389 DEMYELINATION 1 0.0002
390 ARTHRITIS BACTERIAL 1 0.0002
391 ESCHERICHIA INFECTION 2 0.0002
392 BALANCE DISORDER 21 0.0002
393 APPLICATION SITE EXFOLIATION 1 0.0002
394 CYST 3 0.0002
395 DISTURBANCE IN ATTENTION 13 0.0002
396 MIGRAINE 23 0.0002
397 GAIT INABILITY 8 0.0002
398 BONE PAIN 14 0.0002
399 DERMATITIS ALLERGIC 3 0.0002
400 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
401 MUSCLE ATROPHY 3 0.0002
402 BUNDLE BRANCH BLOCK LEFT 1 0.0002
403 INADEQUATE ANALGESIA 2 0.0002
404 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
405 ABSCESS LIMB 1 0.0002
406 ALCOHOLISM 1 0.0002
407 ROTATOR CUFF SYNDROME 3 0.0002
408 PSEUDOMONAS INFECTION 2 0.0002
409 IRRITABLE BOWEL SYNDROME 5 0.0002
410 PARANOIA 4 0.0002
411 LACRIMATION INCREASED 7 0.0002
412 HIATUS HERNIA 3 0.0002
413 NEUROPATHY PERIPHERAL 22 0.0002
414 MUSCLE STRAIN 2 0.0002
415 RASH ERYTHEMATOUS 11 0.0002
416 BONE CANCER 1 0.0002
417 MUSCLE SPASMS 42 0.0002
418 RASH MACULAR 8 0.0002
419 URINE OUTPUT DECREASED 2 0.0002
420 HEART RATE DECREASED 8 0.0002
421 SPINAL OSTEOARTHRITIS 2 0.0002
422 ANKYLOSING SPONDYLITIS 3 0.0002
423 ABDOMINAL ABSCESS 1 0.0002
424 ADVERSE REACTION 3 0.0002
425 VISION BLURRED 31 0.0002
426 CATHETERISATION CARDIAC 1 0.0002
427 BACK PAIN 52 0.0002
428 THROAT IRRITATION 10 0.0002
429 DRUG EFFECT DECREASED 12 0.0002
430 PARAESTHESIA 35 0.0002
431 LOSS OF LIBIDO 2 0.0002
432 THROAT TIGHTNESS 6 0.0002
433 INSOMNIA 59 0.0002
434 UVEITIS 3 0.0002
435 LIMB INJURY 6 0.0002
436 DRUG EFFECT DELAYED 1 0.0002
437 LUPUS-LIKE SYNDROME 2 0.0002
438 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
439 CRYING 8 0.0002
440 ABDOMINAL HERNIA 1 0.0002
441 DIZZINESS 109 0.0002
442 DISEASE COMPLICATION 1 0.0002
443 EAR DISORDER 1 0.0002
444 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
445 BRAIN NEOPLASM 2 0.0002
446 SKIN DISCOLOURATION 10 0.0002
447 INCREASED TENDENCY TO BRUISE 2 0.0002
448 HYPERHIDROSIS 28 0.0002
449 DYSURIA 8 0.0002
450 HYPOMAGNESAEMIA 3 0.0002
451 SWELLING FACE 14 0.0002
452 APHONIA 3 0.0002
453 CHEST DISCOMFORT 22 0.0002
454 SINUSITIS 22 0.0002
455 FEELING OF DESPAIR 1 0.0002
456 BACTERIAL INFECTION 4 0.0002
457 CARPAL TUNNEL SYNDROME 3 0.0002
458 BLOOD TEST ABNORMAL 3 0.0002
459 FLANK PAIN 2 0.0002
460 INJECTION SITE BRUISING 17 0.0002
461 EYE DISORDER 7 0.0002
462 LACERATION 2 0.0002
463 SLEEP DISORDER 15 0.0002
464 LEUKAEMIA 2 0.0002
465 PAIN IN JAW 6 0.0002
466 ARTHRALGIA 88 0.0002
467 FLATULENCE 12 0.0002
468 OCULAR HYPERAEMIA 10 0.0002
469 MUSCULOSKELETAL DISORDER 4 0.0002
470 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
471 DRY MOUTH 17 0.0002
472 FAECAL INCONTINENCE 1 0.0002
473 AFFECT LABILITY 2 0.0002
474 APHAGIA 1 0.0002
475 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
476 INFLUENZA LIKE ILLNESS 17 0.0002
477 PHARYNGEAL SWELLING 2 0.0002
478 MENORRHAGIA 4 0.0002
479 APPLICATION SITE BURN 1 0.0002
480 DIABETIC NEUROPATHY 1 0.0002
481 BLOOD PRESSURE ABNORMAL 4 0.0002
482 ANEURYSM 1 0.0002
483 HYPOTONIA 2 0.0002
484 DRY EYE 10 0.0002
485 DYSPHAGIA 19 0.0002
486 FLUID INTAKE REDUCED 1 0.0002
487 APHASIA 6 0.0002
488 DRUG TOLERANCE 1 0.0002
489 CONTUSION 19 0.0002
490 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
491 PHARYNGEAL OEDEMA 3 0.0002
492 INITIAL INSOMNIA 2 0.0002
493 RIB FRACTURE 4 0.0002
494 MUSCULOSKELETAL STIFFNESS 17 0.0002
495 TEMPERATURE INTOLERANCE 2 0.0002
496 INJECTION SITE ERYTHEMA 24 0.0002
497 RASH GENERALISED 5 0.0002
498 BLOOD CHOLESTEROL INCREASED 9 0.0002
499 TOOTH LOSS 4 0.0002
500 BASAL CELL CARCINOMA 3 0.0002
501 TENDERNESS 2 0.0002
502 WEIGHT FLUCTUATION 2 0.0002
503 SPEECH DISORDER 10 0.0002
504 CYANOSIS 3 0.0002
505 ANXIETY 54 0.0002
506 HALLUCINATION, VISUAL 4 0.0002
507 OSTEOARTHRITIS 8 0.0002
508 DYSGEUSIA 14 0.0002
509 ANORECTAL DISCOMFORT 1 0.0002
510 FEELING ABNORMAL 45 0.0002
511 DRUG DOSE OMISSION 31 0.0002
512 POOR QUALITY SLEEP 4 0.0002
513 ERYTHEMA OF EYELID 1 0.0002
514 FAECES DISCOLOURED 4 0.0002
515 BACK INJURY 2 0.0002
516 MOOD ALTERED 5 0.0002
517 IRRITABILITY 11 0.0002
518 INJECTION SITE SWELLING 14 0.0002
519 WOUND INFECTION 2 0.0002
520 STAPHYLOCOCCAL INFECTION 6 0.0002
521 PERIPHERAL SWELLING 28 0.0002
522 INJECTION SITE NODULE 2 0.0002
523 CHOKING SENSATION 1 0.0002
524 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
525 VISUAL ACUITY REDUCED 6 0.0002
526 VERTIGO 11 0.0002
527 FOOT DEFORMITY 2 0.0002
528 FUNGAL INFECTION 6 0.0002
529 URINARY RETENTION 6 0.0002
530 FATIGUE 140 0.0002
531 INJECTION SITE PRURITUS 12 0.0002
532 URTICARIA 30 0.0002
533 DEMENTIA 5 0.0002
534 BLISTER 10 0.0002
535 SKIN EXFOLIATION 15 0.0002
536 CANDIDA INFECTION 3 0.0002
537 PRURITUS 68 0.0002
538 MITRAL VALVE INCOMPETENCE 2 0.0002
539 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
540 APPLICATION SITE PRURITUS 4 0.0002
541 URINARY TRACT INFECTION 30 0.0002
542 PRODUCT AVAILABILITY ISSUE 4 0.0002
543 ASTHENIA 66 0.0002
544 DERMATITIS CONTACT 2 0.0002
545 ERYTHEMA 36 0.0002
546 CARDIAC VALVE DISEASE 1 0.0002
547 ANGINA PECTORIS 5 0.0002
548 MUSCULOSKELETAL DISCOMFORT 3 0.0002
549 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
550 BLOOD URIC ACID INCREASED 1 0.0002
551 METASTASES TO LUNG 2 0.0002
552 OROPHARYNGEAL PAIN 16 0.0002
553 MADAROSIS 2 0.0002
554 POST PROCEDURAL HAEMORRHAGE 2 0.0002
555 HEART RATE INCREASED 17 0.0002
556 SPINAL PAIN 2 0.0002
557 METASTASES TO LIVER 3 0.0002
558 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
559 COLD SWEAT 3 0.0002
560 NASAL CONGESTION 10 0.0002
561 CATARACT OPERATION 1 0.0002
562 THIRST 3 0.0002
563 HYPERLIPIDAEMIA 2 0.0002
564 MUSCLE RIGIDITY 2 0.0002
565 GOUT 3 0.0002
566 BLOOD GLUCOSE DECREASED 8 0.0002
567 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
568 INJECTION SITE PAIN 51 0.0002
569 GASTROENTERITIS VIRAL 3 0.0002
570 RASH PRURITIC 9 0.0002
571 LOCALISED INFECTION 4 0.0002
572 ARTHRITIS 13 0.0002
573 STOMATITIS 10 0.0002
574 NOCTURIA 2 0.0002
575 NO THERAPEUTIC RESPONSE 2 0.0002
576 RESTLESSNESS 6 0.0002
577 PAIN 100 0.0002
578 DYSPEPSIA 16 0.0002
579 HYPERCALCAEMIA 2 0.0002
580 LIMB DISCOMFORT 5 0.0002
581 CHOLANGITIS 1 0.0002
582 PHARYNGITIS 2 0.0002
583 HEADACHE 101 0.0002
584 ILEUS 2 0.0002
585 INJECTION SITE DISCOLOURATION 2 0.0002
586 SYNCOPE 16 0.0002
587 HEPATIC CIRRHOSIS 3 0.0002
588 DYSARTHRIA 6 0.0002
589 HYPOCALCAEMIA 3 0.0002
590 DEPRESSION 36 0.0002
591 ABDOMINAL PAIN LOWER 4 0.0002
592 JOINT SWELLING 19 0.0002
593 CYSTITIS 5 0.0002
594 LOWER LIMB FRACTURE 3 0.0002
595 MYDRIASIS 2 0.0002
596 ERECTILE DYSFUNCTION 4 0.0002
597 ERUCTATION 3 0.0002
598 APPLICATION SITE VESICLES 1 0.0002
599 NAUSEA 122 0.0002
600 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
601 NERVOUSNESS 8 0.0002
602 BRADYPHRENIA 1 0.0002
603 DEAFNESS 4 0.0002
604 SUICIDAL IDEATION 14 0.0002
605 INCORRECT PRODUCT STORAGE 2 0.0002
606 IMMUNE SYSTEM DISORDER 2 0.0002
607 TOOTH INFECTION 2 0.0002
608 CONSTIPATION 33 0.0002
609 HAEMATOCRIT DECREASED 3 0.0002
610 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
611 DIARRHOEA 97 0.0002
612 RENAL DISORDER 7 0.0002
613 LIP SWELLING 5 0.0001
614 HAIR TEXTURE ABNORMAL 2 0.0001
615 ABDOMINAL DISCOMFORT 25 0.0001
616 PRODUCT PHYSICAL ISSUE 3 0.0001
617 TYPE 2 DIABETES MELLITUS 5 0.0001
618 COLITIS ISCHAEMIC 1 0.0001
619 SINUS CONGESTION 2 0.0001
620 DYSKINESIA 6 0.0001
621 DISCOMFORT 9 0.0001
622 BODY TEMPERATURE INCREASED 3 0.0001
623 IMPAIRED GASTRIC EMPTYING 2 0.0001
624 PRODUCTIVE COUGH 7 0.0001
625 GINGIVAL BLEEDING 2 0.0001
626 DECREASED APPETITE 34 0.0001
627 EYE MOVEMENT DISORDER 1 0.0001
628 HOT FLUSH 11 0.0001
629 CROHN'S DISEASE 1 0.0001
630 ECCHYMOSIS 1 0.0001
631 ABDOMINAL PAIN UPPER 30 0.0001
632 GASTRIC DISORDER 5 0.0001
633 INJECTION SITE REACTION 10 0.0001
634 HAEMATOCHEZIA 8 0.0001
635 ENCEPHALITIS 1 0.0001
636 FALL 48 0.0001
637 MENTAL STATUS CHANGES 4 0.0001
638 SOMNOLENCE 29 0.0001
639 ARTHROPATHY 8 0.0001
640 ORAL DISCOMFORT 2 0.0001
641 AUTOIMMUNE HEPATITIS 1 0.0001
642 FORMICATION 1 0.0001
643 INTENTIONAL DRUG MISUSE 3 0.0001
644 ROAD TRAFFIC ACCIDENT 6 0.0001
645 HAEMOPTYSIS 4 0.0001
646 EXTRASYSTOLES 1 0.0001
647 WITHDRAWAL SYNDROME 6 0.0001
648 DEHYDRATION 19 0.0001
649 APPLICATION SITE REACTION 1 0.0001
650 BLINDNESS UNILATERAL 2 0.0001
651 SEASONAL ALLERGY 2 0.0001
652 LYMPHADENOPATHY 5 0.0001
653 DIVERTICULUM 1 0.0001
654 JOINT INJURY 3 0.0001
655 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
656 HYPERSOMNIA 4 0.0001
657 MOBILITY DECREASED 10 0.0001
658 PARAESTHESIA ORAL 2 0.0001
659 DYSPNOEA 77 0.0001
660 CHEST PAIN 25 0.0001
661 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
662 WHEEZING 8 0.0001
663 VOMITING 63 0.0001
664 WEIGHT INCREASED 30 0.0001
665 RESPIRATORY DISORDER 4 0.0001
666 EPISTAXIS 10 0.0001
667 CHROMATURIA 3 0.0001
668 HEART RATE IRREGULAR 3 0.0001
669 HALLUCINATION 10 0.0001
670 LOSS OF CONSCIOUSNESS 17 0.0001
671 PRODUCT QUALITY ISSUE 18 0.0001
672 UNEVALUABLE EVENT 10 0.0001
673 COUGH 37 0.0001
674 BLOOD COUNT ABNORMAL 2 0.0001
675 OSTEOPENIA 2 0.0001
676 SKIN IRRITATION 6 0.0001
677 NEPHROLITHIASIS 6 0.0001
678 BOWEL MOVEMENT IRREGULARITY 1 0.0001
679 HYPOKALAEMIA 6 0.0001
680 THYROID DISORDER 2 0.0001
681 ATRIOVENTRICULAR BLOCK 1 0.0001
682 MUSCULOSKELETAL CHEST PAIN 2 0.0001
683 VISUAL IMPAIRMENT 16 0.0001
684 RASH 56 0.0001
685 APNOEA 1 0.0001
686 SWELLING 12 0.0001
687 AFFECTIVE DISORDER 1 0.0001
688 PRODUCT USE COMPLAINT 2 0.0001
689 HEAD INJURY 4 0.0001
690 DISORIENTATION 5 0.0001
691 DISEASE RECURRENCE 6 0.0001
692 MOOD SWINGS 4 0.0001
693 ATRIAL FLUTTER 1 0.0001
694 HYPOTHYROIDISM 4 0.0001
695 INJECTION SITE HAEMORRHAGE 10 0.0001
696 BLOOD PRESSURE FLUCTUATION 3 0.0001
697 DIABETIC KETOACIDOSIS 3 0.0001
698 ABDOMINAL DISTENSION 13 0.0001
699 HIP FRACTURE 4 0.0001
700 RHINORRHOEA 8 0.0001
701 FRUSTRATION TOLERANCE DECREASED 1 0.0001
702 CONFUSIONAL STATE 20 0.0001
703 BACK DISORDER 2 0.0001
704 ASPHYXIA 1 0.0001
705 ALOPECIA 24 0.0001
706 HERPES ZOSTER 7 0.0001
707 OSTEOPOROSIS 5 0.0001
708 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
709 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
710 BREAST CANCER STAGE II 1 0.0001
711 COAGULOPATHY 2 0.0001
712 EOSINOPHIL COUNT INCREASED 1 0.0001
713 DRY SKIN 16 0.0001
714 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
715 FACE OEDEMA 2 0.0001
716 MALAISE 52 0.0001
717 HAEMATEMESIS 3 0.0001
718 RENAL FAILURE ACUTE 5 0.0001
719 FACIAL PARALYSIS 1 0.0001
720 SCAR 2 0.0001
721 ANAPHYLACTIC SHOCK 3 0.0001
722 INFLAMMATION 6 0.0001
723 CARDIAC MURMUR 1 0.0001
724 MENTAL DISORDER 5 0.0001
725 APPLICATION SITE ERYTHEMA 3 0.0001
726 DRUG WITHDRAWAL SYNDROME 10 0.0001
727 DEVICE MALFUNCTION 8 0.0001
728 HEAD DISCOMFORT 2 0.0001
729 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
730 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
731 GALLBLADDER DISORDER 2 0.0001
732 GASTROINTESTINAL DISORDER 10 0.0001
733 FREQUENT BOWEL MOVEMENTS 3 0.0001
734 WEIGHT DECREASED 31 0.0001
735 PALLOR 3 0.0001
736 PELVIC PAIN 2 0.0001
737 SKIN LESION 3 0.0001
738 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
739 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
740 HYPERTENSION 23 0.0001
741 BRONCHITIS 8 0.0001
742 FEELING COLD 3 0.0001
743 HEPATIC STEATOSIS 2 0.0001
744 RENAL IMPAIRMENT 9 0.0001
745 DEFORMITY 1 0.0001
746 CARDIAC DISORDER 10 0.0001
747 TARDIVE DYSKINESIA 3 0.0001
748 PHOTOPHOBIA 2 0.0001
749 BLOOD SODIUM DECREASED 2 0.0001
750 RHEUMATOID ARTHRITIS 12 0.0001
751 BLOOD URINE PRESENT 2 0.0001
752 GASTRIC ULCER 2 0.0001
753 FEELING JITTERY 2 0.0001
754 RED BLOOD CELL COUNT DECREASED 3 0.0001
755 SLEEP APNOEA SYNDROME 2 0.0001
756 MULTIPLE SCLEROSIS 5 0.0001
757 PULMONARY FIBROSIS 2 0.0001
758 EYE IRRITATION 6 0.0001
759 PYREXIA 36 0.0001
760 HYPOGLYCAEMIA 5 0.0001
761 HEPATIC ENZYME INCREASED 7 0.0001
762 AUTOIMMUNE DISORDER 1 0.0001
763 SURGERY 6 0.0001
764 KIDNEY INFECTION 2 0.0001
765 BODY TEMPERATURE DECREASED 1 0.0001
766 DISABILITY 2 0.0001
767 SINUS DISORDER 2 0.0001
768 PRESCRIBED UNDERDOSE 2 0.0001
769 AGGRESSION 5 0.0001
770 BLOOD POTASSIUM DECREASED 3 0.0001
771 BRAIN INJURY 1 0.0001
772 THROMBOSIS 8 0.0001
773 EMPHYSEMA 1 0.0001
774 OEDEMA PERIPHERAL 12 0.0001
775 EYELID PTOSIS 1 0.0001
776 INJURY ASSOCIATED WITH DEVICE 2 0.0001
777 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
778 SKIN BURNING SENSATION 7 0.0001
779 ASTHMA 11 0.0001
780 LUNG NEOPLASM MALIGNANT 4 0.0001
781 FEMUR FRACTURE 3 0.0001
782 EYE DISCHARGE 1 0.0001
783 SWOLLEN TONGUE 3 0.0001
784 CARDIO-RESPIRATORY ARREST 4 0.0001
785 ECZEMA 5 0.0001
786 CONDITION AGGRAVATED 29 0.0001
787 FOLLICULITIS 1 0.0001
788 AGITATION 7 0.0001
789 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
790 ABDOMINAL PAIN 22 0.0001
791 EATING DISORDER 2 0.0001
792 BREAST PAIN 1 0.0001
793 LIVER FUNCTION TEST INCREASED 2 0.0001
794 BREAST CANCER METASTATIC 1 0.0001
795 RECTAL HAEMORRHAGE 4 0.0001
796 ATRIAL FIBRILLATION 9 0.0001
797 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
798 NASOPHARYNGITIS 17 0.0001
799 OEDEMA 5 0.0001
800 BIPOLAR DISORDER 1 0.0001
801 DIABETES MELLITUS 7 0.0001
802 PRODUCT PRESCRIBING ISSUE 2 0.0001
803 HYPERSENSITIVITY 17 0.0001
804 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
805 INTENTIONAL PRODUCT MISUSE 8 0.0001
806 OSTEONECROSIS 3 0.0001
807 ASPIRATION 1 0.0001
808 BLOOD GLUCOSE FLUCTUATION 1 0.0001
809 APPLICATION SITE PAIN 2 0.0001
810 INFUSION RELATED REACTION 6 0.0001
811 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
812 BLOOD PRESSURE DECREASED 6 0.0001
813 BLOOD GLUCOSE INCREASED 17 0.0001
814 TACHYCARDIA 8 0.0001
815 EYE PRURITUS 3 0.0001
816 RASH PAPULAR 2 0.0001
817 ADVERSE DRUG REACTION 8 0.0001
818 OXYGEN SATURATION DECREASED 5 0.0001
819 FISTULA 1 0.0001
820 BLOOD CALCIUM DECREASED 1 0.0001
821 CHOLECYSTECTOMY 1 0.0001
822 LETHARGY 5 0.0001
823 SEIZURE 10 0.0001
824 PERICARDIAL EFFUSION 2 0.0001
825 ELECTROLYTE IMBALANCE 1 0.0001
826 EYELID OEDEMA 1 0.0001
827 ARRHYTHMIA 4 0.0001
828 BACTERAEMIA 1 0.0001
829 COMA 4 0.0001
830 THERAPY INTERRUPTED 6 0.0001
831 C-REACTIVE PROTEIN INCREASED 3 0.0001
832 BURSITIS 1 0.0001
833 ADRENAL INSUFFICIENCY 1 0.0001
834 ILL-DEFINED DISORDER 5 0.0001
835 ACCIDENTAL OVERDOSE 3 0.0001
836 CARDIOMEGALY 1 0.0001
837 APPLICATION SITE IRRITATION 1 0.0001
838 INTESTINAL OBSTRUCTION 3 0.0001
839 BRAIN OEDEMA 1 0.0001
840 HYPOPHAGIA 2 0.0001
841 ILLNESS 8 0.0001
842 UNRESPONSIVE TO STIMULI 2 0.0001
843 PNEUMONIA 25 0.0001
844 BLOOD CREATININE INCREASED 5 0.0001
845 GASTRITIS 2 0.0001
846 DEPRESSED MOOD 4 0.0001
847 DYSMENORRHOEA 1 0.0001
848 BRADYCARDIA 4 0.0001
849 EAR INFECTION 2 0.0001
850 EYE HAEMORRHAGE 1 0.0001
851 NEOPLASM MALIGNANT 5 0.0001
852 EXTRA DOSE ADMINISTERED 3 0.0001
853 NEUTROPHIL COUNT DECREASED 3 0.0001
854 PNEUMONITIS 2 0.0001
855 AKATHISIA 1 0.0001
856 ACUTE HEPATIC FAILURE 1 0.0001
857 CORONARY ARTERY OCCLUSION 1 0.0001
858 APPLICATION SITE RASH 1 0.0001
859 RESPIRATORY ARREST 2 0.0001
860 SEPSIS 8 0.0001
861 INTENTIONAL DOSE OMISSION 2 0.0001
862 BRONCHOSPASM 1 0.0001
863 VAGINAL HAEMORRHAGE 3 0.0001
864 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
865 MYOCARDIAL INFARCTION 12 0.0001
866 LIVER FUNCTION TEST ABNORMAL 2 0.0001
867 RESPIRATORY FAILURE 5 0.0001
868 LABORATORY TEST ABNORMAL 2 0.0001
869 CARDIOMYOPATHY 1 0.0001
870 LIVER DISORDER 3 0.0001
871 DRUG INEFFECTIVE 89 0.0001
872 URINARY INCONTINENCE 2 0.0001
873 RENAL INJURY 2 0.0001
874 COLON CANCER 1 0.0001
875 PULMONARY OEDEMA 3 0.0001
876 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
877 THERAPEUTIC RESPONSE DECREASED 4 0.0001
878 CHRONIC KIDNEY DISEASE 5 0.0001
879 INJECTION SITE RASH 2 0.0001
880 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
881 BONE DENSITY DECREASED 2 0.0001
882 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
883 INFLUENZA 7 0.0001
884 BLOOD POTASSIUM INCREASED 1 0.0001
885 LUNG DISORDER 3 0.0001
886 IMPAIRED HEALING 2 0.0001
887 CARDIAC ARREST 5 0.0001
888 DRUG LEVEL INCREASED 1 0.0001
889 VIRAL INFECTION 2 0.0001
890 BLOOD UREA INCREASED 1 0.0001
891 CELLULITIS 3 0.0001
892 TOXICITY TO VARIOUS AGENTS 10 0.0001
893 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
894 PRODUCT USE ISSUE 11 0.0001
895 HAEMATURIA 2 0.0001
896 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
897 AMENORRHOEA 1 0.0001
898 HYPERKALAEMIA 2 0.0001
899 INCORRECT DOSE ADMINISTERED 13 0.0001
900 HYPOXIA 2 0.0001
901 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
902 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
903 PRODUCT ADHESION ISSUE 2 0.0001
904 INFECTION 8 0.0001
905 DRUG EFFECT INCOMPLETE 2 0.0001
906 HYPERGLYCAEMIA 2 0.0001
907 PRODUCT DOSE OMISSION ISSUE 16 0.0001
908 ANAPHYLACTIC REACTION 3 0.0001
909 CONJUNCTIVITIS 1 0.0001
910 FRACTURE 1 0.0001
911 COLITIS 2 0.0001
912 FOOT FRACTURE 1 0.0001
913 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
914 DRUG PRESCRIBING ERROR 1 0.0001
915 ACUTE RESPIRATORY FAILURE 1 0.0001
916 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
917 COVID-19 9 0.0001
918 PLASMA CELL MYELOMA 2 0.0001
919 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
920 ABNORMAL BEHAVIOUR 2 0.0001
921 DRUG INTERACTION 8 0.0001
922 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
923 CYTOKINE RELEASE SYNDROME 1 0.0000
924 PSORIATIC ARTHROPATHY 2 0.0000
925 RHABDOMYOLYSIS 2 0.0000
926 DERMATITIS 1 0.0000
927 HYPOACUSIS 2 0.0000
928 SEPTIC SHOCK 2 0.0000
929 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
930 COLITIS ULCERATIVE 2 0.0000
931 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
932 THERAPY NON-RESPONDER 2 0.0000
933 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
934 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
935 INJURY 3 0.0000
936 PULMONARY EMBOLISM 4 0.0000
937 DRUG INTOLERANCE 4 0.0000
938 CEREBROVASCULAR ACCIDENT 7 0.0000
939 ENCEPHALOPATHY 1 0.0000
940 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
941 HYPOTENSION 8 0.0000
942 ACNE 3 0.0000
943 ACUTE KIDNEY INJURY 6 0.0000
944 HOSPITALISATION 6 0.0000
945 HAEMOGLOBIN DECREASED 4 0.0000
946 PSORIASIS 5 0.0000
947 ANHEDONIA 1 0.0000
948 PANCREATITIS 2 0.0000
949 BLOOD BILIRUBIN INCREASED 1 0.0000
950 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
951 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
952 OFF LABEL USE 31 0.0000
953 CONVULSION 2 0.0000
954 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
955 BLADDER CANCER 2 0.0000
956 CATARACT 2 0.0000
957 DEVICE ISSUE 3 0.0000
958 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
959 PLEURAL EFFUSION 2 0.0000
960 DRUG ADMINISTRATION ERROR 1 0.0000
961 CHOLELITHIASIS 1 0.0000
962 RENAL FAILURE 4 0.0000
963 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
964 HAEMORRHAGE 3 0.0000
965 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
966 UNDERDOSE 2 0.0000
967 DYSPNOEA EXERTIONAL 1 0.0000
968 ANAEMIA 5 0.0000
969 DISEASE PROGRESSION 3 0.0000
970 CARDIAC FAILURE 2 0.0000
971 CARDIAC FAILURE CONGESTIVE 2 0.0000
972 TREATMENT FAILURE 2 0.0000
973 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
974 ANGIOEDEMA 1 0.0000
975 BREAST CANCER 2 0.0000
976 FLUID RETENTION 1 0.0000
977 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
978 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
979 PLATELET COUNT DECREASED 2 0.0000
980 DEATH 16 0.0000
981 NO ADVERSE EVENT 3 0.0000
982 DEEP VEIN THROMBOSIS 1 0.0000
983 DEVICE DIFFICULT TO USE 1 0.0000
984 FEBRILE NEUTROPENIA 1 0.0000
985 OVERDOSE 3 0.0000
986 DRUG ABUSE 1 0.0000
987 ADVERSE EVENT 1 0.0000
988 EMOTIONAL DISTRESS 1 0.0000
989 DRUG DEPENDENCE 1 0.0000